| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |